These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12835615)

  • 21. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer.
    Hunter DJ; Hankinson SE; Hough H; Gertig DM; Garcia-Closas M; Spiegelman D; Manson JE; Colditz GA; Willett WC; Speizer FE; Kelsey K
    Carcinogenesis; 1997 Nov; 18(11):2127-32. PubMed ID: 9395212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
    Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette smoking, glutathione-s-transferase M1 and t1 genetic polymorphisms, and breast cancer risk (United States).
    Zheng T; Holford TR; Zahm SH; Owens PH; Boyle P; Zhang Y; Wise JP; Stephenson LP; Ali-Osman F
    Cancer Causes Control; 2002 Sep; 13(7):637-45. PubMed ID: 12296511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.
    Gertig DM; Stampfer M; Haiman C; Hennekens CH; Kelsey K; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1001-5. PubMed ID: 9829708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.
    Moore LE; Baris DR; Figueroa JD; Garcia-Closas M; Karagas MR; Schwenn MR; Johnson AT; Lubin JH; Hein DW; Dagnall CL; Colt JS; Kida M; Jones MA; Schned AR; Cherala SS; Chanock SJ; Cantor KP; Silverman DT; Rothman N
    Carcinogenesis; 2011 Feb; 32(2):182-9. PubMed ID: 21037224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
    Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
    Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study.
    Tiemersma EW; Kampman E; Bueno de Mesquita HB; Bunschoten A; van Schothorst EM; Kok FJ; Kromhout D
    Cancer Causes Control; 2002 May; 13(4):383-93. PubMed ID: 12074508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
    Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA
    Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group.
    Bartsch H; Malaveille C; Lowenfels AB; Maisonneuve P; Hautefeuille A; Boyle P
    Eur J Cancer Prev; 1998 Jun; 7(3):215-23. PubMed ID: 9696930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of NAT2, GSTT1, and GSTM1 gene polymorphisms withprostate cancer risk in Bangladeshi population.
    Nesa A; Mostafijur Rahman M; Tahminur Rahman M; Kabir Y
    Gene; 2023 Jun; 868():147368. PubMed ID: 36963735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
    Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
    Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.
    Hou SM; Ryberg D; Fält S; Deverill A; Tefre T; Børresen AL; Haugen A; Lambert B
    Carcinogenesis; 2000 Jan; 21(1):49-54. PubMed ID: 10607733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J; Liang D; Wang Y; Lu C; Wu X
    Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
    Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marine n-3 fatty acid intake, glutathione S-transferase polymorphisms and breast cancer risk in post-menopausal Chinese women in Singapore.
    Gago-Dominguez M; Castelao JE; Sun CL; Van Den Berg D; Koh WP; Lee HP; Yu MC
    Carcinogenesis; 2004 Nov; 25(11):2143-7. PubMed ID: 15256483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
    Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
    Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.